Our Mission:
Develop innovative, targeted, immune modulating biotherapeutics to address unmet medical needs in patients with cancer and autoimmune diseases.

The premier biotherapeutic targeting company

Our powerful AbiLeap™ discovery engine combines massively parallel, continuously learning AI with an extensive database of antigen-antibody interactions to generate fully human, IgG-based multispecific antibodies of exquisite selectivity and affinity. The antibodies respond to environmental signals within the cellular microenvironment, generating logic-gated therapeutics.

We are dedicated to developing the most potent and selective antibody therapeutics for areas of great unmet need. 

Biotechnology

Life Sciences

Pharmaceutical

Ability Biologics

Ability Biologics' headquarters in Montreal, Canada

Description

People (2)

Jobs (0)

Other offices